Insulet Corporation

Insulet to Participate in BofA Securities 2026 Health Care Conference

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes